Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/41705
Title: Hampered by historical paradigms - echinocandins and the treatment of Candida endocarditis.
Authors: Korman T. ;Gardiner B.J.;Slavin M.A.;Stuart R.L. 
Monash Health Department(s): Infectious Diseases and Clinical Microbiology
Institution: (Gardiner, Korman, Stuart) Monash Infectious Diseases, Monash Medical Centre, Clayton, VIC., Australia (Slavin) Peter MacCallum Cancer Centre and Faculty of Medicine, University of Melbourne, Melbourne, VIC., Australia (Korman, Stuart) Department of Medicine, Monash University, Clayton, VIC., Australia
Issue Date: 16-Apr-2014
Copyright year: 2014
Publisher: Blackwell Publishing Ltd (E-mail: customerservices@oxonblackwellpublishing.com)
Place of publication: United Kingdom
Publication information: Mycoses. 57 (5) (pp 316-319), 2014. Date of Publication: May 2014.
Journal: Mycoses
Abstract: Summary: Infective endocarditis due to Candida sp. has a high mortality rate. Traditionally, management involves early surgery and prolonged amphotericin +/- flucytosine. We report a case of Candida parapsilosis bileaflet mitral valve endocarditis cured with anidulafungin and fluconazole, and review the role of echinocandins in the management of Candida endocarditis. © 2013 Blackwell Verlag GmbH.
DOI: http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1111/myc.12154
Link to associated publication: Click here for full text options
PubMed URL: 24251958 [http://www.ncbi.nlm.nih.gov/pubmed/?term=24251958]
ISSN: 0933-7407
URI: https://repository.monashhealth.org/monashhealthjspui/handle/1/41705
Type: Article
Subjects: anidulafungin/iv [Intravenous Drug Administration]
fluconazole/iv [Intravenous Drug Administration]
fluconazole/po [Oral Drug Administration]
flucytosine/cb [Drug Combination]
flucytosine/dt [Drug Therapy]
flucytosine/po [Oral Drug Administration]
anidulafungin/dt [Drug Therapy]
creatinine/ec [Endogenous Compound]
fluconazole/dt [Drug Therapy]
fluconazole/cb [Drug Combination]
*echinocandin/dt [Drug Therapy]
acute kidney failure/si [Side Effect]
adult
antifungal susceptibility
article
blood culture
*Candida endocarditis/dt [Drug Therapy]
Candida endocarditis/dt [Drug Therapy]
Candida parapsilosis
case report
creatinine blood level
drug substitution
drug withdrawal
echocardiography
fever
heart catheterization
human
male
middle aged
minimum inhibitory concentration
mitral valve
night sweat
physical examination
priority journal
pulmonary hypertension
transthoracic echocardiography
treatment outcome
amphotericin B
amphotericin B lipid complex/ae [Adverse Drug Reaction]
amphotericin B lipid complex/cb [Drug Combination]
amphotericin B lipid complex/dt [Drug Therapy]
anidulafungin/cb [Drug Combination]
echocardiography
fever
heart catheterization
human
male
middle aged
minimum inhibitory concentration
mitral valve
night sweat
physical examination
priority journal
pulmonary hypertension
transthoracic echocardiography
treatment outcome
acute kidney failure / side effect
Candida parapsilosis
case report
creatinine blood level
drug substitution
drug withdrawal
*Candida endocarditis / *drug therapy
blood culture
article
antifungal susceptibility
adult
Candida endocarditis / drug therapy
Type of Clinical Study or Trial: Case series or case report
Appears in Collections:Articles

Show full item record

Page view(s)

32
checked on Aug 31, 2024

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.